Here's a rapid-fire update on our 33-stock portfolio, including Cramer's 6 favorites to buy

10 hours ago

Rare disease is taking his vision. A gene therapy could help — if he can get it

10 hours ago

Jim Cramer says investors are too focused on AI stocks. Here's where he says to look instead

2 days ago

'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat

2 days ago

AstraZeneca's COPD drug shows late-stage trial wins, boosts blockbuster hopes

2 days ago

Pharma major Novartis falls 10% after three drug trial setbacks

2 days ago

Cholesterol drug setback casts doubt over multibillion-dollar race

2 days ago

Billionaire family offices back healthcare and biotech startups in August

7 days ago

Cramer: Here are 3 defensive stock market moves I'm making as oil and rates surge

9 days ago

We're adding 2 stocks to our Bullpen watchlist because they meet these criteria

9 days ago

This medical device stock looks like a gift for patient investors

9 days ago

August was the month of the comeback kids. Cramer reviews what drove the biggest winners

10 days ago

Trump strikes new drug pricing deals with nine midsized drugmakers

10 days ago

BioCryst is profitable. Now it wants to buy more rare disease drugs

13 days ago

How Taylor Farms became integral to America's food supply system

13 days ago

FDA approves daily HIV pill from Gilead designed to simplify treatment

13 days ago

HHS plans new FDA leadership roles for technology and drugs, sources say

14 days ago

Why vaccination rates are falling in the U.S.

16 days ago

BioMarin to acquire Alesta Therapeutics for $275 million

20 days ago

Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar

22 days ago

Hims & Hers CEO says FTC lawsuit misunderstands how the company works

23 days ago

The startup using AI to help rare disease families develop custom treatments

23 days ago

Court rules companies can't import Gilead medications from overseas

23 days ago

Novo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'

29 days ago

Trump administration ends Medicaid, CHIP funding for gender-affirming care for children

30 days ago

We're lifting our price target on Cardinal Health after issuing rosy profit guidance

30 days ago

Trump wants to split the MMR vaccine. Experts say that's unlikely

30 days ago

Jazz Pharmaceuticals to buy Actio Biosciences for $820 million

30 days ago

Eli Lilly takes weight-loss pill battle global

30 days ago

Trump signs order calling for fewer childhood vaccines, falsely linking shots to autism

30 days ago

New genetic tests are catching rare diseases before symptoms start

1 month ago

Why we like Boeing's latest deal — plus, what to expect from this health stock

1 month ago